Back to Companies Directory
VERIFIED COMPANY DOSSIER

contextual genomics

Verified Intel

Contextual Genomics is a Canadian company launched in 2012 to develop and deliver genomic-based molecular diagnostics to cancer patients. We are developing a suite of genomics-based cancer tests to improve cancer prevention, treatment and monitoring. Combining extensive scientific experience, multiple genomics-based tests and support from pharmaceutical and diagnostic partners, Contextual Genomics is leading the shift towards personalized cancer care.

Contextual Genomics is a Canadian company launched in 2012 to develop and deliver genomic-based molecular diagnostics to cancer patients. We are developing a suite of genomics-based cancer tests to improve cancer prevention, treatment and monitoring. Combining extensive scientific experience, multiple genomics-based tests and support from pharmaceutical and diagnostic partners, Contextual Genomics is leading the shift towards personalized cancer care.

Primary SectorBiotechnology
Workforce Size11-50 Employees
Global HQUndisclosed, Canada
Total Capital RaisedBootstrapped / Private

Corporate Firmographics

Entity classification and operating profile

Industry
Biotechnology
Company Type
Privately Held
Founded
Undisclosed
Employee Bracket
11-50
Estimated Revenue Range
Undisclosed

Geographic Coordinates

Headquarters address and regional territory

Street Address
2389 Health Sciences Mall British Columbia Vancouver
City
—
Region / State
—
Postal Code
V6T
Country
Canada

Digital Presence & Footprint

Verified domains, socials, and directory profiles

Official Domaincontextualgenomics.com
Visit Site
LinkedIn NetworkActive Profile
Open LinkedIn
OUTREACH AUTOMATION

Target Decision-Makers at contextual genomics

Connect your mailboxes, set up your autonomous SDR Agent, and start generating hyper-personalized pipeline for accounts like contextual genomics in minutes.

SYNTHESIZED INTEL

Frequently Asked Questions

Verified business inquiries and firmographic telemetry for contextual genomics.